Dr. Marshall explains procedures MedStar and Georgetown have instituted to ensure your safety while you receive the best care possible
Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute
Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients
Please help us keep the momentum going with a generous gift of any size today to our Summer of Support Drive!
Dr. John L. Marshall addresses some of the questions he and his Georgetown Lombardi colleagues have been hearing most often from current cancer patients and survivors. Learn More
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Justice Ruth Bader Ginsburg says she is being treated for recurrence of cancer
July 20th, 2020
“The treatment she is getting is typical for pancreatic cancer. That would fit,” said John L. Marshall, director of the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center. “But her cancer history is very unusual, from a good perspective. She’s always done much better than one would have anticipated.”
Dr. Jill Smith Receives Pancreatic Cancer Action Network Innovative Research Competitive Grant
July 7th, 2020
In this Pancreatic Cancer Action Network Translational Research Grant project, Dr. Smith’s team will study the effects of a drug, proglumide, and its actions to render pancreatic cancer more responsive to therapy.
Practice-Changing GI Cancer Highlights From Virtual ASCO 2020
July 7th, 2020
Dr. John Marshall shares his personal highlights of GI cancers research from this year’s ASCO conference. There were a lot of important, practice-changing data and he touches on some big-picture themes that are really starting to hit home in GI cancer.
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.
